4//SEC Filing
Madden Martin J. 4
Accession 0001645113-21-000078
CIK 0001645113other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:22 PM ET
Size
8.1 KB
Accession
0001645113-21-000078
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Madden Martin J.
Director
Transactions
- Award
Options to Buy Ordinary Shares
2021-06-09+1,499→ 1,499 totalExercise: $211.89Exp: 2031-06-09→ Ordinary Shares (1,499 underlying) - Award
Restricted Stock Units
2021-06-09+814→ 15,620 total
Holdings
- 418(indirect: Indirect)
Ordinary Shares
Footnotes (3)
- [F1]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.
- [F2]Represents shares indirectly beneficially owned by Mr. Madden that are held by his child with whom he shares a residence. Mr. Madden disclaims beneficial ownership of these shares.
- [F3]Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001696864
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 4:22 PM ET
- Size
- 8.1 KB